Literature DB >> 8065467

Mechanisms of renal vasoconstriction following furosemide in conscious rats.

B J Janssen1, P H Eerdmans, J F Smits.   

Abstract

Regional hemodynamics following intravenous injection of furosemide were studied in conscious rats instrumented with Doppler flowprobes. Furosemide caused a dose-dependent acute (within 3 min) transient increase in renal resistance (RR) followed by a later generalized vasoconstriction in the renal, mesenteric and hindquarter (HQR) vascular bed. With in vitro experiments a possible direct effect of furosemide on renal artery segments was excluded. The acute rise in RR was partly (approximately 40%) attenuated by pretreatment with phentolamine or prazosin, but not prevented by renal denervation, volume repletion or pretreatment with captopril, losartan, indomethacin, aminophylline, nifedipine, or a vasopressin V1A-receptor-antagonist. However, the acute renal vasoconstriction was absent in water diuretic rats. The later vasoconstriction was blunted by captopril (RR+HQR), losartan (RR) and phentolamine (HQR) pretreatment. We conclude that the later generalized vasoconstriction following furosemide involves regional specific stimulation of angiotensin II and alpha-adrenoceptors. The mechanism of the acute renal vasoconstriction could not be fully determined. Because of its absence in water diuretic rats, its rapid onset, transient nature and relative insensitivity for pharmacological tools in euvolemic rats, the acute increase in RR following furosemide may be caused by cell swelling as a result from dissipation of the renal medullary gradient.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8065467     DOI: 10.1007/bf00169143

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  41 in total

1.  Mechanisms of cell volume regulation by the mouse medullary thick ascending limb of Henle.

Authors:  A M Sun; S N Saltzberg; D Kikeri; S C Hebert
Journal:  Kidney Int       Date:  1990-12       Impact factor: 10.612

2.  The dose-response characteristics of the acute non-diuretic peripheral vascular effects of frusemide in normal subjects.

Authors:  G D Johnston; D P Nicholls; W J Leahey
Journal:  Br J Clin Pharmacol       Date:  1984-07       Impact factor: 4.335

3.  Effect of furosemide on renal autoregulation.

Authors:  K L Duchin; L N Peterson; T J Burke
Journal:  Kidney Int       Date:  1977-12       Impact factor: 10.612

4.  Acute arteriolar vasoconstriction following furosemide in conscious spontaneously hypertensive rats.

Authors:  B J Janssen; H A Struyker-Boudier; J F Smits
Journal:  Eur J Pharmacol       Date:  1989-10-24       Impact factor: 4.432

5.  Tubular sites of furosemide natriuresis in volume-replaced and volume-depleted conscious rats.

Authors:  S Christensen; E Steiness; H Christensen
Journal:  J Pharmacol Exp Ther       Date:  1986-10       Impact factor: 4.030

6.  Compensatory pressor role of vasopressin following acute diuresis.

Authors:  D J DiPette; A H Rogers
Journal:  J Hypertens       Date:  1988-08       Impact factor: 4.844

7.  The effect of furosemide on vascular smooth muscle is influenced by plasma protein.

Authors:  F Andreasen; J H Christensen
Journal:  Pharmacol Toxicol       Date:  1988-11

8.  Role of prostaglandins in the hemodynamic and tubular effects of furosemide.

Authors:  J G Gerber
Journal:  Fed Proc       Date:  1983-04

9.  Furosemide-induced vasodilation: importance of the state of hydration and filtration.

Authors:  J G Gerber; A S Nies
Journal:  Kidney Int       Date:  1980-10       Impact factor: 10.612

10.  Regional blood flow measurement with pulsed Doppler flowmeter in conscious rat.

Authors:  J R Haywood; R A Shaffer; C Fastenow; G D Fink; M J Brody
Journal:  Am J Physiol       Date:  1981-08
View more
  1 in total

1.  Acute effects of the anti-inflammatory cyclooxygenase-2 selective inhibitor, flosulide, on renal plasma flow and glomerular filtration rate in rats.

Authors:  A Turull; C Piera; J Queralt
Journal:  Inflammation       Date:  2001-04       Impact factor: 4.092

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.